INS and metabolic syndrome: showed that sCD36 concentration in the serum of patients with coronary heart disease was negatively correlated with uric acid and insulin concentration, HOMA‐IR ratio, and BMI but positively correlated with high‐density lipoprotein and apolipoprotein A1 concentration, suggesting a protective effect of higher sCD36 on metabolic syndrome components.69